Remimazolam Tosylate

DRUG3 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., RenJi Hospital

Conditions

AnesthesiaGastric CancerHealthyHypoxiaPropofol Adverse ReactionSedation Complication

Phase 1

A Phase Ⅰa Study of Remimazolam Tosylate in Healthy Volunteers

CompletedNCT01970072

Jiangsu HengRui Medicine Co., Ltd.Healthy

Start: 2013-10-14End: 2014-06-20Updated: 2018-01-31

A Phase Ⅰb Study of Remimazolam Tosylate in Healthy Volunteers

CompletedNCT03444480

Jiangsu HengRui Medicine Co., Ltd.Anesthesia

Start: 2014-07-23End: 2014-08-16Updated: 2018-02-23

Unknown Phase

Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

RenJi HospitalGastric Cancer, Hypoxia, Propofol Adverse Reaction +1

Start: 2021-03-02End: 2023-08-01Target: 1800Updated: 2022-10-12

Related Papers

Effect of remimazolam tosilate for injection (HR7056) versus sevoflurane on the incidence of postoperative delirium in older patients undergoing total hip arthroplasty: study protocol for a prospective, multicentre, two-arm, parallel-group, randomised controlled trial.

2025-02-18

Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial

Trials2022-12-1213 citations

Efficacy and Safety of Remimazolam Tosilate Combined With Esketamine for Analgesic Sedation in Mechanically Ventilated ICU Patients: A Single-Arm Clinical Study Protocol

Frontiers in Medicine2022-03-1718 citations

Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.

2020-03-1386 citations

Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects

Frontiers in Pharmacology2018-11-1931 citations